Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.7200 (5.95%) ($8.7200 - $8.8000) on Tue. Apr. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.02% (three month average) | RSI | 53 | Latest Price | $8.7200(5.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.1% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.1% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(70%) ARKG(68%) ARKK(65%) IWO(63%) IBB(61%) | Factors Impacting CGEN price | CGEN will decline at least -2.51% in a week (0% probabilities). VIXM(-45%) VXX(-37%) UUP(-19%) TLT(-5%) IGOV(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.51% (StdDev 5.02%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.53(-106.08%) | Inflection Point | Yes | 5 Day Moving Average | $8.41(3.69%) | 10 Day Moving Average | $8.57(1.75%) | 20 Day Moving Average | $8.58(1.63%) | To recent high | -36.9% | To recent low | 14.4% | Market Cap | $721m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |